Clinical-stage companies have no sales history, but they still have demand. Here’s how to uncover the four streams driving supply planning before material gets tight.
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- CSM Feasibility Begins With Research Strategy And Study Design
- Clinical Supply Systems Need IT General Controls
- AI-Generated Data, Patent Protection, And The Implications For Clinical Supply
- The End Of Just-In-Time? Why Clinical Trial Supply Chains Are Rethinking Inventory Strategy
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Last-Mile Lessons For Depot-To-Site Delivery
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
ON-DEMAND WEBINARS
This webinar provides strategies for clinical supply planners to make immediate improvements in their strategy as well as discuss the need for a holistic end-to-end approach to supply planning.
Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.
This session presents a risk-based framework for high-potency micronisation, illustrated through a practical case study that spans development to commercial scale.
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-1155553590-syringe-glove-doctor-vaccine-medicine]( "Overcome Vaccine Development Complexities With The Right Supply Chain Partner")
Overcome Vaccine Development Complexities With The Right Supply Chain PartnerExplore the challenges impacting clinical supply chains and solutions to overcome these complexities, and understand why it is crucial to pick the right supply chain provider for vaccine storage and distribution.
-
![GettyImages-1221576332 cell therapy]( "Logistics In Cell Therapy: Reducing Workflow Risk")
Logistics In Cell Therapy: Reducing Workflow RiskExplore key steps that should be taken when executing a cell therapy clinical trial, from selecting the right sites to optimizing study retention.
-
![Panademic Related Manufacturing Complications]( "Outsourcers Are Feeling Uneasy About Continuity Of Supply")
Outsourcers Are Feeling Uneasy About Continuity Of SupplyFind out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
-
![iStock-635767756-clinical-trial-research]( "Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain")
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply ChainFlexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
![West]( "Vial Containment Systems For Gene And Cell Therapies")
Vial Containment Systems For Gene And Cell TherapiesCZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
![Future Technology Science]( "Effective Use Of IRT In Decentralized And Hybrid Clinical Trials")
Effective Use Of IRT In Decentralized And Hybrid Clinical TrialsUncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
![GettyImages-1391646149 technology]( "Providing Drug Supply Support In Complex Environments Through IRT")
Providing Drug Supply Support In Complex Environments Through IRTLearn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
![GettyImages-1331571740-supply-chain-sourcing-logistics-tracking]( "The Dual Sourcing Approach")
The Dual Sourcing ApproachHaving a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
![GettyImages-1212860058 clinical trial patient]( "24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments")
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical ShipmentsGet an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
![supply chain management, pharma business logistics-GettyImages-960991960]( "What Is Interactive Response Technology (IRT)?")
What Is Interactive Response Technology (IRT)?Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
- Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
